NIH has awarded 58 new research grants through its High-Risk, High-Reward Research program to support exceptionally innovative research with the potential for broad impact on biomedical and behavioral science.
As the debate around Galleri, the multi-cancer detection test developed by GRAIL Inc., rages on, fueled most recently by the full-steam-ahead support it has received from regulatory and legislative bodies, NCI Director Anthony Letai has turned his attention to the available data.
